Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet (multiple letters)

International Journal of Clinical Practice

Volumn 58, Issue 3, 2004, Pages 322-

  Lines, C ^a   Visser, W H ^a   Dowson, A J ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

COMPARATIVE STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG PACKAGING; EVIDENCE BASED MEDICINE; HUMAN; LETTER; MIGRAINE; PRESCRIPTION; PRIORITY JOURNAL; TABLET DISINTEGRATION; TABLET FORMULATION; TASTE PREFERENCE;

EID: 2342420509     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2004.0160a.x     Document Type: Letter

References (0)